Search
for
Sort by
Research 30 of 788
- Association of JAK 1 and JAK 2 gene polymorphism with alopecia areata risk: a case–control genetic study
- Translational Positioning of Janus Kinase (JAK) Inhibitors in Alopecia Areata
- Genes and Immune Response in Alopecia Areata: Review of the Alopecia Areata Research Summit First Day Proceedings
- Revolutionary Approaches to Hair Regrowth: Follicle Neogenesis, Wnt/ß-Catenin Signaling, and Emerging Therapies
- Oral ruxolitinib induces hair regrowth in patients with moderate-to-severe alopecia areata
- Alopecia Areata: a Comprehensive Review of Pathogenesis and Management
- Janus Kinase inhibitors in dermatology: a review
- Clinical Perspectives on Alopecia: From Hair Follicle Biology to Advanced Therapies
- 69 Risk-benefit appraisal of systemic JAK inhibitors for alopecia areata: a comprehensive meta-analysis assessing safety and adverse effects
- 54022 Pooled Safety Assessments from the Multinational Phase 3 THRIVE-AA1 and THRIVE-AA2 Trials of Deuruxolitinib in Adult Patients with Moderate to Severe Alopecia Areata
- Short-term Efficacy of Tofacitinib, a JAK Inhibitor, in IFIH1-related Aicardi-Goutières Syndrome
- 42736 Safety Assessments in the Multinational Phase 3 THRIVE-AA1 Trial with CTP-543 (Deuruxolitinib) in Adult Patients with Moderate to Severe Alopecia Areata
- Hair regrowth in a patient with central centrifugal cicatricial alopecia after a 2-month trial of baricitinib
- Low-dose tofacitinib for treating patients with severe alopecia areata: an efficient and cost-saving regimen
- Personalized Medicine in the Field of Inflammatory Skin Disorders
- 455 Molecular correlation with clinical outcomes in an open label clinical trial of oral tofacitinib in patients with alopecia areata
- 695 Selectively targeting JAK1 or JAK3 pathway is sufficient to reverse alopecia areata
- JAK inhibitors in dermatology: The promise of a new drug class
- Alopecia Areata: Case report and review of pathophysiology and treatment with Jak inhibitors
- JAK 1-3 inhibitors and TYK-2 inhibitors in dermatology: Practical pearls for the primary care physician
- JAK-Inhibitors Beyond the Label: Emerging Applications in Dermatology
- JAK1 Signaling Is Involved in the Induction of Mechanical Alloknesis in Atopic Dermatitis
- Case Series: Gene Expression Analysis in Canine Vogt-Koyanagi-Harada/Uveodermatologic Syndrome and Vitiligo Reveals Conserved Immunopathogenesis Pathways Between Dog and Human Autoimmune Pigmentary Disorders
- Application of Baricitinib in Dermatology
- Overview of alopecia areata for managed care and payer stakeholders in the United States
- Current and future pharmacotherapy for alopecia areata
- Upadacitinib: A New Weapon for the Treatment of Twenty-Nail Dystrophy
- An Open-Label Pilot Study to Evaluate the Efficacy of Tofacitinib in Moderate to Severe Patch-Type Alopecia Areata, Totalis, and Universalis
- Novel TMEM173 Mutation and the Role of Disease Modifying Alleles
- STAT5 Activation in the Dermal Papilla Is Important for Hair Follicle Growth Phase Induction